Among the lesions biopsied for research revealing invasive breast carcinoma (N = 98), the majority were hormone receptor-positive (HR +), human epidermal growth factor receptor 2-negative (HER2 –) breast cancer (71.5%), followed by HER2 + breast cancer (16.3%), and TNBC (12.2%). The gene discussed is NR4A1; the disease is invasive breast carcinoma.